Case Details
- Citation: [2024] SGHC 95
- Court: High Court (General Division)
- Case Number: Criminal Case No 47 of 2022
- Date of Judgment: 2 April 2024
- Judges: See Kee Oon JAD
- Plaintiff/Applicant: Public Prosecutor
- Defendant/Respondent: Seet Poh Jing (“Seet”)
- Legal Area: Criminal Law — Misuse of Drugs Act offences (possession for purpose of trafficking)
- Statutes Referenced: Misuse of Drugs Act (Cap 185, 2008 Rev Ed) (“MDA”)
- Key Provisions Discussed: ss 5(1)(a), 5(2), 17, 33(1), 33B(3)(b) of the MDA
- Hearing Dates: 13–14, 16, 20–21 September, 7 November 2022, 25–26, 30 January, 3 February, 16–17 October, 29 December 2023
- Judgment Reserved: Yes
- Judgment Length: 56 pages, 15,770 words
- Proceedings: Seet claimed trial to a charge of having in possession not less than 4509.2g of cannabis mixture for the purpose of trafficking
Summary
In Public Prosecutor v Seet Poh Jing ([2024] SGHC 95), the High Court convicted Seet of possession of not less than 4509.2g of cannabis mixture for the purpose of trafficking under s 5(1)(a) read with s 5(2) of the Misuse of Drugs Act (Cap 185, 2008 Rev Ed) (“MDA”), an offence punishable under s 33(1) of the MDA. The central statutory feature of the case was the operation of the presumption in s 17 of the MDA: once possession is proved, the law presumes that the drug was possessed for the purpose of trafficking unless the accused rebuts the presumption on the balance of probabilities.
The court found that Seet failed to rebut the s 17 presumption. Although Seet advanced a “research defence” (that the cannabis was possessed for research and development of cannabidiol (“CBD”)), the court rejected it as an afterthought and inconsistent with the totality of the evidence. The court also considered Seet’s mental health evidence, including psychiatric reports and the possibility of hypomania, but concluded that this did not undermine the prosecution’s case or Seet’s failure to rebut the trafficking presumption.
What Were the Facts of This Case?
The undisputed background was that Seet was 28 years old at the time of the alleged offence and was working as a property sales agent prior to his arrest. On 28 June 2018, Seet was arrested together with his girlfriend, Elizabeth Leong Ai Ying, at the ground floor lift landing of Block 857 Tampines Street 83. After the arrest, Central Narcotics Bureau (“CNB”) officers escorted Seet to the carpark in front of Block 857.
At about 4.33pm, Seet was searched and several items were recovered from him and seized as case exhibits. Shortly thereafter, at about 5.15pm, Seet was escorted to a white BMW hatchback bearing registration number “SJP9770Z” (the “BMW”), parked at the carpark. The BMW was searched in Seet’s presence. Among the items seized from the car boot were five blocks of vegetable matter wrapped in various plastic and paper materials, later marked as exhibits A1A1, A1B1, B1A1, B1B1A and B1B2A1. These were the drug exhibits forming the subject-matter of the charge.
Later that evening, Seet was escorted to his residential address at Blk 166 Hougang Avenue 1 #03-1576. At about 9.30pm, his bedroom was searched in his presence and additional items were seized. The court noted that drug paraphernalia capable of facilitating drug consumption and trafficking activities were found among the seized items. At about 10.49pm, Seet was brought back to the BMW (towed to Woodlands Checkpoint). When asked whether he had anything in the BMW to surrender, Seet surrendered a white box containing 16 facial cream containers (the “KANA products”), which were seized as exhibit D1A.
Forensic analysis was conducted by the Health Sciences Authority (“HSA”). The HSA found that the five blocks contained not less than 911.6g, 829.4g, 938.4g, 870.1g, and 959.7g respectively of cannabis mixture. The total amount of cannabis mixture was not less than 4509.2g. Seet did not dispute that he was in possession of the drugs and that he knew they were cannabis mixture, which he referred to as “weed”. The chain of custody of the drug exhibits was also not disputed.
In addition, the HSA’s forensic examination found Seet’s DNA profile on multiple components associated with the drug exhibits, including plastic sheets and cling wraps, tapes (sticky and non-sticky sides), and swabs taken from various exhibits. This supported the inference that Seet had handling or close contact with the drug materials.
The court also relied on forensic examination of Seet’s two mobile phones. Messages sent on 30 May 2018 using one of the phones (SPJ-HP2) were treated as advertisements for cannabis. The messages included references to “weed”, “THC Gummies”, and instructions to “PM” for pricing and discounts. Other messages showed Seet introducing himself as “Ganja man” and asking whether the recipient had “people” who wanted “green”, with “green” understood to refer to cannabis mixture.
Seet’s statements to investigators were also part of the evidential matrix. A total of 32 investigative statements were recorded from Seet, including one contemporaneous statement and one cautioned statement on 29 June 2018, and multiple long statements and cautioned statements across subsequent dates. Seet did not challenge the admissibility of any of the statements.
Finally, Seet relied on psychiatric evidence. He was first examined by Dr Kenneth Koh of the Institute of Mental Health (“IMH”), who produced a report dated 20 July 2018. Dr Koh concluded that Seet suffered from a substance use disorder due to consumption of methamphetamine and cannabis, but had no other “major” mental disorder. Later, during the trial, Dr Jacob Rajesh of Promises Healthcare assessed Seet on three occasions in January and February 2023 and produced further opinions relevant to Seet’s mental state, including the possibility of hypomania.
What Were the Key Legal Issues?
The principal legal issue was whether Seet, having been shown to possess the cannabis mixture, had rebutted the statutory presumption under s 17 of the MDA that the drugs were possessed for the purpose of trafficking. This required the court to evaluate whether Seet’s explanation for possession—particularly the “research defence”—was credible and sufficiently supported by the evidence.
A second issue concerned the relevance and effect of Seet’s mental health evidence. The court had to consider whether Seet suffered from hypomania and, if so, whether that condition could affect the assessment of his credibility, his intent, or the reliability of his account. The judgment also referenced s 33B(3)(b) of the MDA, which is typically engaged in sentencing-related contexts where mental conditions may be relevant to culpability and/or the court’s approach to punishment.
Accordingly, the court’s task was not merely to decide whether Seet possessed the drugs, but to determine whether the totality of evidence supported trafficking intent and whether Seet’s rebuttal case—both factual and psychiatric—could displace the presumption in s 17.
How Did the Court Analyse the Issues?
The court began by applying the statutory framework. Once possession was established and the presumption in s 17 was operative, the burden shifted to Seet to rebut the presumption. The court emphasised that the presumption is not displaced by mere assertions; it must be rebutted by evidence that makes it reasonably probable that the drugs were not possessed for trafficking purposes. In this case, Seet did not dispute possession or knowledge that the substances were cannabis mixture. The dispute therefore centred on purpose.
Seet’s primary explanation was the “research defence”, namely that he possessed the cannabis for research and development of CBD. The court treated this defence as problematic on multiple levels. First, it characterised the research defence as an afterthought, suggesting it was not coherently advanced at the earliest opportunity or supported by contemporaneous objective evidence. Second, the court found the defence internally inconsistent. That is, Seet’s narrative about research activity did not align with the practical and forensic evidence found in the car, bedroom, and devices.
Third, the court assessed Seet’s credibility. It found that Seet was not a credible witness. In drug trafficking cases, credibility is often decisive because the accused’s explanation for possession is frequently the only direct account of purpose. Here, the court concluded that Seet’s account did not withstand scrutiny when tested against the forensic findings and communications extracted from his phones.
The court also addressed the evidential significance of Seet’s “enthusiasm for cannabis”. While Seet argued that his interest in cannabis supported a research motive, the court held that such enthusiasm did not prove possession for research and development of CBD. The court reasoned that enthusiasm is compatible with multiple purposes, including trafficking, and cannot by itself rebut the trafficking presumption where other evidence points in the opposite direction.
Crucially, the court found that the totality of the evidence was consistent with Seet having possessed the drugs for the purpose of trafficking. This conclusion was supported by several strands: the large quantity of cannabis mixture (not less than 4509.2g), the presence of drug paraphernalia capable of facilitating consumption and trafficking, the manner in which the drug materials were packaged into multiple blocks, and the DNA findings linking Seet to the drug exhibits. Most importantly, the court relied on the phone messages that appeared to be mass-sent advertisements for cannabis products, including references to pricing, discounts, and product types such as THC gummies.
In analysing the communications, the court treated the messages as evidence of intent and commercial dealing rather than research. The messages were not framed as scientific experimentation or laboratory procurement; instead, they were structured like marketing and customer solicitation. The court also noted that Seet sent these messages before the arrest, which supported the inference that the possession was connected to dealing rather than isolated experimentation.
Alongside the trafficking analysis, the court considered Seet’s psychiatric evidence, including the issue of hypomania. The court examined the expert opinions and the parties’ cases on whether Seet suffered from hypomania. While the extract provided indicates that the court addressed “Whether Seet suffered from hypomania” and then considered “Section 33B(3)(b) of the MDA”, the overall approach can be understood as follows: the court assessed whether the mental condition, if established, could provide a basis to alter the assessment of intent, credibility, or culpability.
Ultimately, the court did not accept that Seet’s mental state undermined the prosecution’s case or the conclusion that he failed to rebut the s 17 presumption. Even where substance use disorder was accepted by Dr Koh, the court’s reasoning indicates that the psychiatric evidence did not supply a coherent alternative explanation for the possession purpose. The court therefore proceeded to convict on the trafficking charge, while also addressing the statutory mental condition provision referenced in s 33B(3)(b) in the context of the overall legal framework.
What Was the Outcome?
The court found that Seet failed to rebut the presumption in s 17 of the MDA. Accordingly, the prosecution proved beyond reasonable doubt that Seet possessed the cannabis mixture for the purpose of trafficking. The conviction followed from the court’s conclusion that the research defence was not credible and that the totality of evidence supported trafficking intent.
The practical effect of the decision is that Seet was convicted of an MDA offence punishable under s 33(1), with the judgment also engaging the statutory framework that may be relevant to sentencing considerations where mental conditions are raised (including the reference to s 33B(3)(b)).
Why Does This Case Matter?
Public Prosecutor v Seet Poh Jing is significant for practitioners because it illustrates how the High Court evaluates attempts to rebut the s 17 trafficking presumption. The judgment demonstrates that courts will scrutinise not only the quantity of drugs and forensic links, but also the coherence and timing of the accused’s explanation. A “research defence” will not succeed where it is treated as an afterthought, internally inconsistent, and contradicted by objective evidence such as communications that resemble marketing and solicitation.
The case also underscores the evidential weight of phone messages in possession-for-trafficking cases. Where messages contain pricing, product descriptions, and instructions to “PM” for discounts, courts may readily infer commercial dealing. This is particularly so when the messages are sent by the accused prior to arrest and align with other trafficking indicators such as packaging, paraphernalia, and DNA contact with the drug exhibits.
Finally, the judgment is useful for understanding the interaction between mental health evidence and drug trafficking intent. While psychiatric reports may be relevant to culpability and sentencing frameworks, the court’s approach indicates that such evidence must meaningfully affect the assessment of purpose or credibility. Where it does not, it will not displace the statutory presumption. For law students and defence counsel, the case is a reminder that mental condition arguments require careful evidential support and must be integrated with the factual narrative rather than presented as a standalone explanation.
Legislation Referenced
Cases Cited
- (Not provided in the supplied extract.)
Source Documents
This article analyses [2024] SGHC 95 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.